Authors
Loading...
This review explores how artificial intelligence and machine learning improve vaccine and immunotherapeutic development, suggesting new approaches to clinical trials.
Elfatimi et al. (2025) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: